basiliximab
ItalyDrugs containing this active substance
-
It is used in hospital for adults, adolescents, and children who are undergoing a kidney transplant. It works by blocking immune cells that could attack the transplanted organ, helping to prevent rejection in the first 4-6 weeks after surgery.
Form: solution for infusion, powder and solvent for preparation
Active substance Dosage basiliximab - ATC: L04AC02
Manufacturer: NOVARTIS EUROPHARM LIMITED